Skip to main content

Advertisement

Table 6 Summary of interim survey respondents affiliated trial subject areas

From: Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership – the PRioRiTy (Prioritising Recruitment in Randomised Trials) study

Trial subject area Number Percentage
Oncology/haematology – cancer 161 21
Neurology – neurodegenerative diseases, vascular diseases 77 10
Cardiology – cardiovascular disease 62 8
Orthopaedics/musculoskeletal 56 7
Mental health 51 7
Metabolism – diabetes mellitus 47 6
Vaccines – preventive vaccines 45 6
Reproductive health 33 4
Critical care 24 3
Infectious diseases 21 3
Gastroenterology – hepatology, nephrology 18 2
Surgery 16 2
Respiratory 15 2
Paediatrics/neonates 13 2
Inflammatory conditions (e.g. osteoarthritis, rheumatoid arthritis, fibromyalgia) 11 1
Ophthalmology 9 1
Involved in multiple trials 34 4
Other 82 11
Totala 785 96
  1. aData missing in 30 respondents